Metrics as of 10/13/2026, 06:52 PM (Berlin time), refresh in progress.
LeMaitre Vascular Stock
LeMaitre Vascular, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- George W. LeMaitre
- Employees
- 651
- Market cap
- $1.9 B
- IPO
- 19/10/2006
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. The company is headquartered in Burlington, Massachusetts, and operates within the healthcare sector as a provider of medical instruments…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
LeMaitre Vascular stock: price history
1D
-1.6%
1W
+3.2%
1M
+1.2%
6M
-30.5%
YTD
+0.6%
1Y
-4.4%
2Y
-10.0%
5Y
+52.5%
10Y
+320.6%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~61% stronger price swings than usual
Ask the agents about LeMaitre Vascular
Analyst assessment of LeMaitre Vascular
PRICE TARGET LOW
US$95.00
CONSENSUS
US$115.00
MEDIAN
US$115.00
PRICE TARGET HIGH
US$135.00
0
STRONG BUY
14
BUY
6
HOLD
0
SELL
0
STRONG SELL
20
TOTAL · Buy
As of: 05/08/2026
LeMaitre Vascular stock metrics
P/E
28.12
P/B
4.43
EV/EBITDA
21.51
RETURN ON EQUITY
4.1%
NET MARGIN
24.2%
DEBT/EQUITY
0.45
DIVIDEND YIELD
1.2%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
93.1%
FLOAT SHARES
21,272,973
AVG. DAILY VOLUME (30D)
264,501
Insider transactions (SEC)
Roush John A
LeMaitre George W
LeMaitre George W
Jasinski Lawrence J
Jasinski Lawrence J
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about LeMaitre Vascular stock
What does LeMaitre Vascular do?
LeMaitre Vascular, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is George W. LeMaitre, the company employs around 651 people.
The IPO was on 19/10/2006; the stock trades on NASDAQ under the ticker LMAT.
What do analysts say about LeMaitre Vascular stock?
20 analysts rate the stock, the consensus is Buy (as of 05/08/2026).
The average price target is US$115.00, ranging from US$95.00 to US$135.00, with a median of US$115.00.
This is an external assessment, not a statement by Market Jury.
When does LeMaitre Vascular report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 61% stronger than usual.
Does LeMaitre Vascular pay a dividend?
Yes. The last dividend was US$0.25 per share, ex-date 20/08/2026, paid on 03/09/2026.
The dividend yield is 1.2% (as of 30/06/2026).
Which stocks are comparable to LeMaitre Vascular?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get LeMaitre Vascular stock analyzed?
Clicking "Analyze stock" lets five strategies assess LeMaitre Vascular against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.